Frailty in Daily Practice: Screening, Consultation and Education Activities
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04139837 |
Recruitment Status :
Suspended
(COVID 19 pandemic)
First Posted : October 25, 2019
Last Update Posted : January 28, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The present study is designed to to estimate the prevalence of frailty and pre-frailty and their associated factors in community-dwelling populations aged 50 years and above in Hong Kong, and to explore the views of participants taking part in a community health talks or activities on frailty about what the participants felt or had gained from participating, concerns, and suggestions for change or improvement.
A survey of 15000 people aged 50 years or older identified in community facilities will be conducted. The participants will be invited to their affiliated centres for a brief screening using the FRAIL scale and assessment. A series of community health talks or activities on frailty will be offered to the participants based on the frailty status.Questionnaire and screening tools will be administered by trained researchers.
Condition or disease | Intervention/treatment |
---|---|
Frailty | Behavioral: Health screening, community health talks or activities on frailty |
A 30-month community survey will be conducted, and the survey will be divided into three phases, namely study preparation and subject recruitment (6 months), data collection (18 months), and data entry and analysis (6 months).
A survey of 15000 people aged 50 years or older identified in community facilities (e.g., neighbourhood elderly centre, social centre for the elderly) will be conducted. The participants will be invited to their affiliated centres for a brief screening using the FRAIL scale and assessment. A series of community health talks or activities on frailty will be offered to the participants based on the frailty status. Questionnaire and screening tools will be administered by trained researchers.
The primary outcome will be the prevalence of frailty and pre-frailty. Secondary outcomes will cover physical performance measures including hand-grip strength and 5-chair stand test. Anthropometric and demographic data will also be collected using standardized methods and questionnaires respectively.
Views of participants taking part in a community health talks or activities on frailty about what the participants felt or had gained from participating, concerns, and suggestions for change or improvement will be explored by client satisfaction questionnaires.
Study Type : | Observational |
Estimated Enrollment : | 15000 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Cross-Sectional |
Official Title: | Frailty in Daily Practice: Screening, Consultation and Education Activities |
Actual Study Start Date : | January 3, 2020 |
Estimated Primary Completion Date : | October 2022 |
Estimated Study Completion Date : | October 2022 |
- Behavioral: Health screening, community health talks or activities on frailty
Screening for frailty using the FRAIL scale to categorize participant's status as robust, prefrail and frail. A series of community health talks or activities on frailty will be provided to each category of participants for the prevention or management of frailty.
- Frailty status [ Time Frame: 1 day (Once only at screening) ]Frailty status (i.e. robust, prefrail or frail) measured using the frailty scale (FRAIL) in which unabbreviated scale name is unavailable for this scale. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) and represent robust (0), pre-frail (1-2), and frail (3-5) health status.
- Handgrip strength [ Time Frame: 1 day (Once only at screening) ]Handgrip strength measured using a dynamometer
- 5 chair stands [ Time Frame: 1 day (Once only at screening) ]Muscle endurance in the lower extremities - Participant will be required to rise from a chair a total of 5 times, as quickly as they could, with arms across their chest. The amount of time required to complete all 5 repetitions will be recorded.
- Weight [ Time Frame: 1 day (Once only at screening) ]Weight in kilogram measured using standardized method
- Height [ Time Frame: 1 day (Once only at screening) ]Height in centimeter measured using standardized method
- Waist circumference [ Time Frame: 1 day (Once only at screening) ]Waist circumference in centimeter measured using standardized method
- Systolic blood pressure [ Time Frame: 1 day (Once only at screening) ]Systolic blood pressure in mmHg measured using standardized method
- Diastolic blood pressure [ Time Frame: 1 day (Once only at screening) ]Diastolic blood pressure in mmHg measured using standardized method

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- People aged 50 years or older
- Chinese origin
- Normally reside in Hong Kong
- Could speak and understand Chinese
- Willing to follow the study procedures
Exclusion Criteria:
-Live in a residential aged care facility

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04139837
China | |
Chinese University of Hong Kong | |
Hong Kong, China |
Principal Investigator: | Jean Woo, MD | Chinese University of Hong Kong |
Responsible Party: | Jean Woo, Professor, Chinese University of Hong Kong |
ClinicalTrials.gov Identifier: | NCT04139837 |
Other Study ID Numbers: |
2019.475 |
First Posted: | October 25, 2019 Key Record Dates |
Last Update Posted: | January 28, 2021 |
Last Verified: | January 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Frailty Pathologic Processes |